{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,2,21]],"date-time":"2025-02-21T07:50:18Z","timestamp":1740124218364,"version":"3.37.3"},"reference-count":23,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2021,11,16]],"date-time":"2021-11-16T00:00:00Z","timestamp":1637020800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2021,11,16]],"date-time":"2021-11-16T00:00:00Z","timestamp":1637020800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"funder":[{"DOI":"10.13039\/501100004844","name":"national cheng kung university hospital","doi-asserted-by":"publisher","award":["NCKUH-11003038"],"award-info":[{"award-number":["NCKUH-11003038"]}],"id":[{"id":"10.13039\/501100004844","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Int Urol Nephrol"],"published-print":{"date-parts":[[2022,1]]},"DOI":"10.1007\/s11255-021-03005-3","type":"journal-article","created":{"date-parts":[[2021,11,16]],"date-time":"2021-11-16T15:02:56Z","timestamp":1637074976000},"page":"63-69","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Is bladder preservation safe? The oncology outcomes of patients after 2-sided radical nephroureterectomies due to bilateral upper urinary tract urothelial carcinomas"],"prefix":"10.1007","volume":"54","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-4147-9041","authenticated-orcid":false,"given":"Yao-Lin","family":"Kao","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Wen-Horng","family":"Yang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6555-0172","authenticated-orcid":false,"given":"Chien-Hui","family":"Ou","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2021,11,16]]},"reference":[{"key":"3005_CR1","doi-asserted-by":"publisher","first-page":"111","DOI":"10.1016\/j.eururo.2017.07.036","volume":"73","author":"M Roupret","year":"2018","unstructured":"Roupret M, Babjuk M, Comperat E et al (2018) European Association of Urology Guidelines on upper urinary tract urothelial carcinoma: 2017 update. Eur Urol 73:111\u2013122","journal-title":"Eur Urol"},{"key":"3005_CR2","doi-asserted-by":"publisher","first-page":"546","DOI":"10.1016\/j.juro.2017.03.120","volume":"198","author":"Q Li","year":"2017","unstructured":"Li Q, Assel M, Benfante N et al (2017) Clinical outcomes in patients with panurothelial carcinoma treated with radical nephroureterectomy following cystectomy for metachronous recurrence. J Urol 198:546\u2013551","journal-title":"J Urol"},{"key":"3005_CR3","doi-asserted-by":"publisher","first-page":"1224","DOI":"10.1002\/cncr.24135","volume":"115","author":"V Margulis","year":"2009","unstructured":"Margulis V, Shariat SF, Matin SF et al (2009) Outcomes of radical nephroureterectomy: a series from the upper tract urothelial carcinoma collaboration. Cancer 115:1224\u20131233","journal-title":"Cancer"},{"key":"3005_CR4","doi-asserted-by":"publisher","first-page":"69","DOI":"10.1016\/S0022-5347(05)00057-1","volume":"175","author":"S Holm\u00e4ng","year":"2006","unstructured":"Holm\u00e4ng S, Johansson SL (2006) Bilateral metachronous ureteral and renal pelvic carcinomas: incidence, clinical presentation, histopathology, treatment and outcome. J Urol 175:69\u201372 (discussion 72\u201363)","journal-title":"J Urol"},{"key":"3005_CR5","doi-asserted-by":"publisher","first-page":"623","DOI":"10.1007\/s11255-017-1522-1","volume":"49","author":"CH Ou","year":"2017","unstructured":"Ou CH, Yang WH (2017) Long-term outcomes of complete urinary tract exenteration for dialysis patients with urothelial cancer. Int Urol Nephrol 49:623\u2013627","journal-title":"Int Urol Nephrol"},{"key":"3005_CR6","doi-asserted-by":"publisher","first-page":"69","DOI":"10.1016\/S0022-5347(05)00057-1","volume":"175","author":"S Holmang","year":"2006","unstructured":"Holmang S, Johansson SL (2006) Bilateral metachronous ureteral and renal pelvic carcinomas: incidence, clinical presentation, histopathology, treatment and outcome. J Urol 175:69\u201372","journal-title":"J Urol"},{"key":"3005_CR7","doi-asserted-by":"publisher","first-page":"66.e61-11","DOI":"10.1016\/j.urolonc.2014.07.001","volume":"33","author":"D Fang","year":"2015","unstructured":"Fang D, Xiong G, Li X et al (2015) Incidence, characteristics, treatment strategies, and oncologic outcomes of synchronous bilateral upper tract urothelial carcinoma in the Chinese population. Urol Oncol 33:66.e61\u201311","journal-title":"Urol Oncol"},{"key":"3005_CR8","doi-asserted-by":"publisher","first-page":"399","DOI":"10.1038\/bjc.1986.65","volume":"53","author":"CJ Chen","year":"1986","unstructured":"Chen CJ, Chuang YC, You SL, Lin TM, Wu HY (1986) A retrospective study on malignant neoplasms of bladder, lung and liver in blackfoot disease endemic area in Taiwan. Br J Cancer 53:399\u2013405","journal-title":"Br J Cancer"},{"key":"3005_CR9","doi-asserted-by":"publisher","first-page":"1226","DOI":"10.1016\/j.eururo.2008.08.008","volume":"54","author":"M Roupr\u00eat","year":"2008","unstructured":"Roupr\u00eat M, Yates DR, Comperat E, Cussenot O (2008) Upper urinary tract urothelial cell carcinomas and other urological malignancies involved in the hereditary nonpolyposis colorectal cancer (lynch syndrome) tumor spectrum. Eur Urol 54:1226\u20131236","journal-title":"Eur Urol"},{"key":"3005_CR10","first-page":"2195","volume-title":"Campbell Walsh Wein urology","author":"P Kallidonis","year":"2021","unstructured":"Kallidonis P, Liatsikos E (2021) Urothelial tumors of the upper urinary tract and ureter. In: Partin AW, Dmochowski RR, Kavoussi LR, Peters CA (eds) Campbell Walsh Wein urology, vol 2, 12th edn. Elsevier, Philadelphia, p 2195","edition":"12"},{"key":"3005_CR11","doi-asserted-by":"publisher","first-page":"378","DOI":"10.1111\/iju.13054","volume":"23","author":"S Yamashita","year":"2016","unstructured":"Yamashita S, Ito A, Mitsuzuka K et al (2016) Clinical implications of intravesical recurrence after radical nephroureterectomy for upper urinary tract urothelial carcinoma. Int J Urol 23:378\u2013384","journal-title":"Int J Urol"},{"key":"3005_CR12","doi-asserted-by":"publisher","first-page":"61","DOI":"10.1007\/s00345-012-0957-3","volume":"31","author":"E Xylinas","year":"2013","unstructured":"Xylinas E, Colin P, Audenet F et al (2013) Intravesical recurrence after radical nephroureterectomy for upper tract urothelial carcinomas: predictors and impact on subsequent oncological outcomes from a national multicenter study. World J Urol 31:61\u201368","journal-title":"World J Urol"},{"key":"3005_CR13","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1016\/S0022-5347(17)55269-6","volume":"124","author":"T Kakizoe","year":"1980","unstructured":"Kakizoe T, Fujita J, Murase T, Matsumoto K, Kishi K (1980) Transitional cell carcinoma of the bladder in patients with renal pelvic and ureteral cancer. J Urol 124:17\u201319","journal-title":"J Urol"},{"key":"3005_CR14","doi-asserted-by":"publisher","first-page":"1122","DOI":"10.1016\/j.eururo.2014.11.035","volume":"67","author":"T Seisen","year":"2015","unstructured":"Seisen T, Granger B, Colin P et al (2015) A systematic review and meta-analysis of clinicopathologic factors linked to intravesical recurrence after radical nephroureterectomy to treat upper tract urothelial carcinoma. Eur Urol 67:1122\u20131133","journal-title":"Eur Urol"},{"key":"3005_CR15","doi-asserted-by":"publisher","first-page":"130","DOI":"10.1016\/j.urolonc.2009.06.003","volume":"29","author":"MD Az\u00e9mar","year":"2011","unstructured":"Az\u00e9mar MD, Comperat E, Richard F, Cussenot O, Roupr\u00eat M (2011) Bladder recurrence after surgery for upper urinary tract urothelial cell carcinoma: frequency, risk factors, and surveillance. Urol Oncol 29:130\u2013136","journal-title":"Urol Oncol"},{"key":"3005_CR16","doi-asserted-by":"publisher","first-page":"14","DOI":"10.1002\/ijc.28013","volume":"133","author":"CH Chen","year":"2013","unstructured":"Chen CH, Dickman KG, Huang CY et al (2013) Aristolochic acid-induced upper tract urothelial carcinoma in Taiwan: clinical characteristics and outcomes. Int J Cancer 133:14\u201320","journal-title":"Int J Cancer"},{"key":"3005_CR17","doi-asserted-by":"publisher","first-page":"1852","DOI":"10.1093\/ndt\/17.10.1852","volume":"17","author":"C Van Ypersele De Strihou","year":"2002","unstructured":"Van Ypersele De Strihou C, Jadoul M (2002) Progression rate of Chinese herb nephropathy: impact of Aristolochia fangchi ingested dose. Nephrol Dial Transplant 17:1852","journal-title":"Nephrol Dial Transplant"},{"key":"3005_CR18","doi-asserted-by":"publisher","first-page":"1512","DOI":"10.1093\/ndt\/gfm167","volume":"22","author":"JL Nortier","year":"2007","unstructured":"Nortier JL, Vanherweghem JL (2007) For patients taking herbal therapy\u2013lessons from aristolochic acid nephropathy. Nephrol Dial Transplant 22:1512\u20131517","journal-title":"Nephrol Dial Transplant"},{"key":"3005_CR19","doi-asserted-by":"publisher","first-page":"327","DOI":"10.1111\/iju.14188","volume":"27","author":"HL Luo","year":"2020","unstructured":"Luo HL, Ohyama C, Hatakeyama S et al (2020) Unusual presentation of upper urinary tract urothelial carcinoma in Taiwan: Direct comparison from Taiwan\u2013Japan UTUC Collaboration Cohort. Int J Urol 27:327\u2013332","journal-title":"Int J Urol"},{"key":"3005_CR20","first-page":"2187","volume-title":"Campbell Walsh Wein urology","author":"P Kallidonis","year":"2021","unstructured":"Kallidonis P, Liatsikos E (2021) Urothelial tumors of the upper urinary tract and ureter. In: Partin AW, Dmochowski RR, Kavoussi LR, Peters CA (eds) Campbell Walsh Wein urology, vol 2, 12th edn. Elsevier, Philadelphia, p 2187","edition":"12"},{"key":"3005_CR21","doi-asserted-by":"publisher","first-page":"764","DOI":"10.1056\/NEJMcp1714533","volume":"379","author":"FA Sinicrope","year":"2018","unstructured":"Sinicrope FA (2018) Lynch syndrome-associated colorectal cancer. N Engl J Med 379:764\u2013773","journal-title":"N Engl J Med"},{"key":"3005_CR22","doi-asserted-by":"publisher","first-page":"265","DOI":"10.14423\/SMJ.0000000000000633","volume":"110","author":"S Singh","year":"2017","unstructured":"Singh S, Resnick KE (2017) Lynch syndrome and endometrial cancer. South Med J 110:265\u2013269","journal-title":"South Med J"},{"key":"3005_CR23","doi-asserted-by":"publisher","first-page":"48","DOI":"10.1111\/j.1464-410X.2008.07565.x","volume":"102","author":"LB Tan","year":"2008","unstructured":"Tan LB, Chen KT, Guo HR (2008) Clinical and epidemiological features of patients with genitourinary tract tumour in a blackfoot disease endemic area of Taiwan. BJU Int 102:48\u201354","journal-title":"BJU Int"}],"container-title":["International Urology and Nephrology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11255-021-03005-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s11255-021-03005-3\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11255-021-03005-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,1,5]],"date-time":"2022-01-05T11:40:26Z","timestamp":1641382826000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s11255-021-03005-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,11,16]]},"references-count":23,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2022,1]]}},"alternative-id":["3005"],"URL":"https:\/\/doi.org\/10.1007\/s11255-021-03005-3","relation":{},"ISSN":["0301-1623","1573-2584"],"issn-type":[{"type":"print","value":"0301-1623"},{"type":"electronic","value":"1573-2584"}],"subject":[],"published":{"date-parts":[[2021,11,16]]},"assertion":[{"value":"14 July 2021","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"24 September 2021","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"16 November 2021","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no conflicts of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflicts of interest"}},{"value":"The study was commenced after approval from the Institutional Review Board of National Cheng Kung University Hospital (NCKUH; A-ER-103-036).","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval"}},{"value":"Not applicable.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent to participate"}},{"value":"Informed consent was waived due to the retrospective nature of the data analysis.","order":5,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}}]}}